Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,023 | -3,467 | 15,347 | N/A | 6,188 |
| Depreciation Amortization | 232 | 257 | 452 | N/A | 345 |
| Accounts receivable | -4,812 | -2,104 | -353 | N/A | N/A |
| Accounts payable and accrued liabilities | -210 | -899 | -1,408 | N/A | -13 |
| Other Working Capital | 1,050 | -4,011 | -1,834 | N/A | -23,096 |
| Other Operating Activity | 15,620 | -4,467 | -1,041 | 0 | 4,749 |
| Operating Cash Flow | $-143 | $-14,691 | $11,163 | $N/A | $-11,827 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 52,463 | -103,228 | 80,236 | N/A | -69,048 |
| PPE Investments | N/A | N/A | N/A | N/A | -94 |
| Investing Cash Flow | $52,463 | $-103,228 | $80,236 | $N/A | $-69,142 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,085 | 564 | 1,101 | N/A | 1,642 |
| Common Stock Repurchased | N/A | N/A | -26,207 | N/A | N/A |
| Other Financing Activity | -85,401 | -9 | 298 | 0 | 62 |
| Financing Cash Flow | $-83,316 | $555 | $-24,808 | $N/A | $1,704 |
| Beginning Cash Position | 35,794 | 153,158 | 86,567 | N/A | 95,651 |
| End Cash Position | 4,798 | 35,794 | 153,158 | N/A | 16,386 |
| Net Cash Flow | $-30,996 | $-117,364 | $66,591 | $N/A | $-79,265 |
| Free Cash Flow | |||||
| Operating Cash Flow | -143 | -14,691 | 11,163 | N/A | -11,827 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -94 |
| Free Cash Flow | -143 | -14,691 | 11,163 | 0 | -11,921 |